ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
Processa Pharmaceuticals Inc

Processa Pharmaceuticals Inc (PCSA)

0,682
-0,048
(-6,58%)
Fermé 26 Janvier 10:00PM
0,67
-0,012
(-1,76%)
Après les heures de négociation: 12:01AM

Outils de qualité professionnelle, pour des investisseurs individuels.

Statistiques et détails clés

Dernier
0,67
Prix Achat
0,5321
Prix Vente
0,90
Volume échangé
48 358
0,6578 Fourchette du Jour 0,727899
0,67 Plage de 52 semaines 5,9099
Cap du marché
Clôture Veille
0,73
Ouverture
0,7101
Dernière Transaction
2000
@
0.67
(formt)
Dernière heure de transaction
Volume financier
US$ 33 463
VWAP
0,691978
Volume moyen (3 m)
372 004
Actions en circulation
3 266 944
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-0,20
Bénéfice par action (BPA)
-3,4
Chiffre d'affairess
-
Bénéfice net
-11,12M

À propos de Processa Pharmaceuticals Inc

Processa Pharmaceuticals Inc is a clinical-stage biopharmaceutical company based in the United States. It focuses on the development of drug products that are intended to improve the survival and quality of life for patients who have an unmet medical need. The company's lead product, PCS499 is an or... Processa Pharmaceuticals Inc is a clinical-stage biopharmaceutical company based in the United States. It focuses on the development of drug products that are intended to improve the survival and quality of life for patients who have an unmet medical need. The company's lead product, PCS499 is an oral tablet that is an analog of an active metabolite of an already approved drug. It focuses on fibrotic related diseases such as focal segmental glomerulosclerosis, idiopathic pulmonary fibrosis. Its pipeline products comprise PCS6422, PCS12852, and PCS100. Show more

Secteur
Pharmaceutical Preparations
Industrie
Pharmaceutical Preparations
Siège social
Wilmington, Delaware, USA
Fondé
-
Processa Pharmaceuticals Inc est coté dans le secteur Pharmaceutical Preparations de la NASDAQ avec le ticker PCSA. Le dernier cours de clôture d'Processa Pharmaceuticals était de US$0,73. Au cours de la dernière année, les actions de Processa Pharmaceuticals ont été négociées dans une fourchette de prix de US$ 0,67 à US$ 5,9099.

Processa Pharmaceuticals compte actuellement 3 266 944 actions en circulation. La capitalisation boursière d'Processa Pharmaceuticals est de US$2,38 million. Processa Pharmaceuticals a un ratio cours/bénéfice (ratio PE) de -0.20.

PCSA Dernières nouvelles

Processa Pharmaceuticals Reports Third Quarter Business Highlights and Financial Results

First patient dosed in Phase 2 clinical trial with NGC-Cap for metastatic breast cancer Positive data from preclinical studies support NGC-Iri’s ability to deliver more SN-38 to tumors compared...

Processa Pharmaceuticals Announces First Patient Dosed in Phase 2 Clinical Trial of NGC-Cap in Metastatic Breast Cancer

Phase 2 trial is an adaptive designed randomized study comparing NGC-Cap to monotherapy capecitabineResults from this Phase 2 trial will evaluate NGC-Cap’s safety-efficacy profile and help to...

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
1-0.169-20.14302741360.8390.8390.67707950.74237381CS
4-0.2295-25.51417454140.89951.080.67665930.86127119CS
12-0.5-42.7350427351.171.50.673720041.26673636CS
26-1.06-61.27167630061.733.10.676803921.98060414CS
52-1.63-70.86956521742.35.90990.6710839243.04028264CS
156-76.13-99.127604166776.890.40.676939886.71107885CS
260-75.33-99.118421052676284.7980.6750241512.23295379CS

PCSA - Frequently Asked Questions (FAQ)

What is the current Processa Pharmaceuticals share price?
The current share price of Processa Pharmaceuticals is US$ 0,67
How many Processa Pharmaceuticals shares are in issue?
Processa Pharmaceuticals has 3 266 944 shares in issue
What is the market cap of Processa Pharmaceuticals?
The market capitalisation of Processa Pharmaceuticals is USD 2,38M
What is the 1 year trading range for Processa Pharmaceuticals share price?
Processa Pharmaceuticals has traded in the range of US$ 0,67 to US$ 5,9099 during the past year
What is the PE ratio of Processa Pharmaceuticals?
The price to earnings ratio of Processa Pharmaceuticals is -0,2
What is the reporting currency for Processa Pharmaceuticals?
Processa Pharmaceuticals reports financial results in USD
What is the latest annual profit for Processa Pharmaceuticals?
The latest annual profit of Processa Pharmaceuticals is USD -11,12M
What is the registered address of Processa Pharmaceuticals?
The registered address for Processa Pharmaceuticals is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
Which industry sector does Processa Pharmaceuticals operate in?
Processa Pharmaceuticals operates in the PHARMACEUTICAL PREPARATIONS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
NVNINVNI Group Ltd
US$ 4,38
(193,96%)
366,98M
EVAXEvaxion Biotech AS
US$ 5,99
(64,56%)
55,41M
ELABPMGC Holdings Inc
US$ 3,0901
(56,07%)
76,48M
PCLAPicoCELA Inc
US$ 4,60
(49,35%)
3,75M
GOEVCanoo Inc
US$ 0,475
(43,94%)
282,22M
GODNUGolden Star Acquisition Corporation
US$ 3,11
(-75,82%)
17,51k
GODNGolden Star Acquisition Corporation
US$ 2,93
(-65,67%)
902,76k
NXTTNext Technology Holding Inc
US$ 1,37
(-54,93%)
2,56M
SGLYSingularity Future Technology Ltd
US$ 1,625
(-38,45%)
917,77k
WHLRLWheeler Real Estate Investment Trust Inc
US$ 90,11
(-38,07%)
8
ACONAclarion Inc
US$ 0,0557
(28,94%)
811,91M
NVNINVNI Group Ltd
US$ 4,38
(193,96%)
366,98M
RIMEAlgorhythm Holdings Inc
US$ 0,0357
(4,69%)
284,97M
GOEVCanoo Inc
US$ 0,475
(43,94%)
282,22M
NVDANVIDIA Corporation
US$ 142,62
(-3,12%)
232,88M
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

Delayed Upgrade Clock